Economy‘Patients pay the tariff’: Swiss pharma CEO warns of Trump’s generic-drug tariff threat

Sandoz CEO Richard Saynor warns that steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or reduce supply, leaving patients to bear the cost.

U.S. tariffsgeneric drugspharmaceuticals

CCNBC★★★☆☆2026-09-08 13:31Original